National Natural Science Foundation of China (81860050 & 81460044), Yunnan Fundamental Research Projects
(202201AY070001–040), Yunnan Health Training Project of High
Levels Talents (L-2018007), Yunnan Provincial Ten Thousand-Talent
Program-Famous Doctor (YNWR-MY-2018–043), Yunnan Provincial
Department of Education (K13219554 & K13219451), and Innovation
Funding for Postgraduates of Kunming Medical University
(No.2022B23).
语种:
外文
高被引:
热点:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类|2 区医学
小类|1 区药学2 区医学:研究与实验
最新[2023]版:
大类|2 区医学
小类|1 区药学2 区医学:研究与实验
JCR分区:
出版当年[2022]版:
Q1MEDICINE, RESEARCH & EXPERIMENTALQ1PHARMACOLOGY & PHARMACY
最新[2023]版:
Q1MEDICINE, RESEARCH & EXPERIMENTALQ1PHARMACOLOGY & PHARMACY
第一作者机构:[1]Department of Anesthesiology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China
共同第一作者:
通讯作者:
通讯机构:[1]Department of Anesthesiology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China[*1]Department of Anesthesiology, First Affiliated Hospital of Kunming Medical University, 295 Xichang Road, Kunming, Yunnan 650032, PR China.
推荐引用方式(GB/T 7714):
Wang Zhuoran,Yao Mengran,Jiang Leyu,et al.Dexmedetomidine attenuates myocardial ischemia/reperfusion-induced ferroptosis via AMPK/GSK-3β/Nrf2 axis[J].BIOMEDICINE & PHARMACOTHERAPY.2022,154:113572.doi:10.1016/j.biopha.2022.113572.
APA:
Wang Zhuoran,Yao Mengran,Jiang Leyu,Wang Lingyan,Yang Yuqiao...&Qian Jinqiao.(2022).Dexmedetomidine attenuates myocardial ischemia/reperfusion-induced ferroptosis via AMPK/GSK-3β/Nrf2 axis.BIOMEDICINE & PHARMACOTHERAPY,154,
MLA:
Wang Zhuoran,et al."Dexmedetomidine attenuates myocardial ischemia/reperfusion-induced ferroptosis via AMPK/GSK-3β/Nrf2 axis".BIOMEDICINE & PHARMACOTHERAPY 154.(2022):113572